Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 124.00p 123.00p 125.00p 124.00p 124.00p 124.00p 0 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 165.6 8.4 6.3 19.8 130.00

Cello Health Share Discussion Threads

Showing 976 to 999 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
06/2/2017
12:32
OK if a tech=backed model, what p/e or EV/EBITDA ratio will the market ascribe to CLL? Presume much higher than now, hence the re-rate? DYOR
qs99
06/2/2017
12:24
thanks for that. also decent yield IMO
qs99
06/2/2017
12:06
FinnCap; Post the placing, Cello has net cash and, with an acquisition, has signalled its intent to invest for growth now that the VAT issue is firmly behind it. We continue to believe Pulsar, its social media tool, is in the share price for free, but also increasingly that Cello has developed a widening range of technologies that are performing well and support good profit growth potential. Cello is moving away from an ‘hours utilised and billed' type model towards a technology-backed model, a more valuable proposition.
davebowler
01/2/2017
11:39
The oversubscribed placing underpins the share price and there is all to play for in 2017
zipstuck
01/2/2017
09:27
well that was unexpected but a nice surprise....any thoughts on this very quiet board?
qs99
19/1/2017
09:36
Price: 100.0p Target Price: 132.0p finncap.com Cello has confirmed the Group delivered an encouraging trading performance in 2016 and 2017 begins with good momentum from existing and new clients. Most importantly for our buy case, there has been an ‘excellent performance’ from Cello’s growing suite of software-enabled products. We make no changes to our forecasts and continue to believe the share price significantly undervalues the technologies Cello has developed, most notably Pulsar its social media analytics tool which we believe is in the price for free.
davebowler
04/1/2017
08:08
looks like some NY demand again, ticking up on the open
qs99
21/12/2016
12:05
bit of demand again...
qs99
08/12/2016
14:51
and some more
qs99
05/12/2016
16:03
NY until next update, but nice to see continued small steps...DYOR etc,
qs99
02/12/2016
16:18
and some more before the weekend...sir
qs99
02/12/2016
13:00
up and down like a ......showing some more life today, let's hope it can keep its northwards movement this time...
qs99
19/10/2016
13:05
showing some life again
qs99
04/10/2016
12:33
hopefully any seller now out of the way....Xd in a few days, all helps, and rising share price ...
qs99
28/9/2016
09:58
Finncap; Price: 106.0p Target Price: 132p Cello has an overlooked and potentially significantly undervalued asset that is now out of development phase. Cello Pulsar is a social media analytics tool that has significant points of difference to the competition. In the right hands, social media data can inform, direct and optimise marketing campaigns but to date its usage has been constrained by early-stage science and customer unfamiliarity. Competitors in this area have individually raised nearly half of Cello's market cap, emphasising Pulsar’s potential to add very material value to the share price. We initiate at Buy.
davebowler
27/9/2016
14:22
Cello Group CEO Mark Scott will be presenting at the Proactive One2One Forum on the evening of 6th October at the Chesterfield Mayfair Hotel. For details and registration,please click here: http://tinyurl.com/zmac6hu
aim_trader
20/9/2016
09:13
Nice little bowl forming...hope next leg up to start shortly! Yield getting nice IMO
qs99
14/9/2016
18:18
The point about the dividend is that they have declared a new policy of 40% payout. With eps for the full year forecast at 9p that would give a final payment of 2.6p and the interim/final payment ratio would be similar to previous years. The reasons for the dividend increase are set out in this July interview: hTtps://youtu.be/5mZO1i3hBp4 Today's interview here: hTtps://www.youtube.com/watch?v=dzH_ImhdNv4
sharw
14/9/2016
18:00
Dividend up 19%. 1m shares issued, just over 1%. Sounds ok for shareholders overall to me.
markie7
14/9/2016
17:49
Sorry - poorly phrased. One fifth of a penny. To off-set a notional decline of 2-3p in your share price created by dilution.
coopstock
14/9/2016
17:43
Interim div increased by 19% not 1 fifth of a percent!!
markie7
14/9/2016
17:36
Markie7 Can't access the recent newsfeed, but think they recently reported over a million new shares issued under performance plan (with almost a million more to be allocated as and when they choose). No problem with that, but it does equate to adding 2% to total shares in circulation - with consequent downward pressure on share price Meanwhile they've raised the interim dividend by a fifth of one percent (perhaps with a bit more to come at full year). Again, no complaints about that - but it's interesting context before everyone gets carried away by the dividend hike. As for the VAT debacle, just go back through the various trading statements. First they were confident they had no case to answer, then that they could reach a reasonable settlement with HMRC,then that although they had to pay out to HMRC in full they fully expected to reclaim the funds from clients... Total reclaimed so far - nul points. And these clients are charities - the clue is in the name - so won't be holding my breath. Bottom line, I like this company and very glad to have got in when I did back in the dog days of 2010. But was expecting a bit more - especially from Cello Health in America. The dollars they make will add 5-10% to their full year due to the post-Brexit pound, so I'm relatively optimistic. Not QS99 optimistic, but...
coopstock
14/9/2016
16:49
Coopstock, can you talk me through the maths on the block listing and your dividend point please? Also point out where the company has promised the VAT would be recovered? I can't quite see how either point works?
markie7
14/9/2016
16:17
Presentation slides now available: hTtp://www.cellogroup.com/wp-content/uploads/2016/03/Interim-Results-September-2016.pdf.pdf
sharw
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190626 07:45:34